Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × OTHER_GOV × Bevacizumab × Clear all

Phase

Phase 2 13 Phase 2/3 4 Phase NA 1 Phase EARLY_PHASE1 1 Phase 3 1 Phase 1 1

Status

Sponsor Class

INDUSTRY 115 OTHER 74 NIH 26 NETWORK 9 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Radiotherapy 8 Carboplatin 6 Capecitabine 6 Fluorouracil 5 Cisplatin 5 Paclitaxel 4 Gemcitabine 4 Docetaxel 4 Tamoxifen 3 Oxaliplatin 3 Neoadjuvant Therapy 3 Hydralazine 3 Etoposide 3 Drug Therapy 3 Cyclophosphamide 3 pegylated granulocyte colony-stimulating factor 2 palbociclib 2 Valproic Acid 2 Trastuzumab 2 Tranexamic Acid 2 Temozolomide 2 TP protocol 2 Surgical Procedures, Operative 2 Saline Solution 2 Radiotherapy, Adjuvant 2 Proton Pump Inhibitors 2 Pemetrexed 2 Nivolumab 2 Leucovorin 2 Irinotecan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04776655 2025-10-02

LIBImAb

Azienda USL Reggio Emilia - IRCCS

Phase 3 Recruiting

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡